Coding mutations in Tumor protein 53 (TP53) and β-catenin (CTNNB1), along with promoter mutations in Telomerase reverse transcriptase (TERT) that increase TERT transcript levels, were the most frequent trunk mutations in 151 samples of HCC in various stages of tumor progression [16]. This evidence concerns the gene CTNNB1 and neoplasm.